These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 15514228)

  • 1. The Global Alliance for Vaccines and Immunization: is it a new model for effective public-private cooperation in international public health?
    Muraskin W
    Am J Public Health; 2004 Nov; 94(11):1922-5. PubMed ID: 15514228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introducing new vaccines in the poorest countries: what did we learn from the GAVI experience with financial sustainability?
    Lydon P; Levine R; Makinen M; Brenzel L; Mitchell V; Milstien JB; Kamara L; Landry S
    Vaccine; 2008 Dec; 26(51):6706-16. PubMed ID: 18952134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New tendencies and strategies in international immunisation: GAVI and The Vaccine Fund.
    Martin JF; Marshall J
    Vaccine; 2003 Jan; 21(7-8):587-92. PubMed ID: 12531322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The GAVI Financing Task Force: one model of partner collaboration.
    Milstien JB; Kamara L; Lydon P; Mitchell V; Landry S
    Vaccine; 2008 Dec; 26(51):6699-705. PubMed ID: 19306508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of the GAVI Alliance to improving health and reducing poverty.
    Lob-Levyt J
    Philos Trans R Soc Lond B Biol Sci; 2011 Oct; 366(1579):2743-7. PubMed ID: 21893535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supporting countries in establishing and strengthening NITAGs: lessons learned from 5 years of the SIVAC initiative.
    Adjagba A; Senouci K; Biellik R; Batmunkh N; Faye PC; Durupt A; Gessner BD; da Silva A
    Vaccine; 2015 Jan; 33(5):588-95. PubMed ID: 25545597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shifts in global immunisation goals (1984-2004): unfinished agendas and mixed results.
    Hardon A; Blume S
    Soc Sci Med; 2005 Jan; 60(2):345-56. PubMed ID: 15522490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustainability of National Immunization Programme (NIP) performance and financing following Global Alliance for Vaccines and Immunization (GAVI) support to the Democratic Republic of the Congo (DRC).
    Le Gargasson JB; Breugelmans JG; Mibulumukini B; Da Silva A; Colombini A
    Vaccine; 2013 Apr; 31(15):1886-91. PubMed ID: 23462529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Global Alliance for Vaccines and Immunization (GAVI) in Accelerating Inactivated Polio Vaccine Introduction.
    Thacker N; Thacker D; Pathak A
    Indian Pediatr; 2016 Aug; 53 Suppl 1():S57-S60. PubMed ID: 27771641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Country-level governance of global health initiatives: an evaluation of immunization coordination mechanisms in five countries of Asia.
    Grundy J
    Health Policy Plan; 2010 May; 25(3):186-96. PubMed ID: 19926659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for financial sustainability of immunization programs: a review of the strategies from 50 national immunization program financial sustainability plans.
    Kamara L; Milstien JB; Patyna M; Lydon P; Levin A; Brenzel L
    Vaccine; 2008 Dec; 26(51):6717-26. PubMed ID: 18955100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs of vaccine programs across 94 low- and middle-income countries.
    Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
    Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
    Peny JM; Gleizes O; Covilard JP
    Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the private sector in the provision of immunization services in low- and middle-income countries.
    Levin A; Kaddar M
    Health Policy Plan; 2011 Jul; 26 Suppl 1():i4-12. PubMed ID: 21729916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. World Health Organization perspectives on the contribution of the Global Alliance for Vaccines and Immunization on reducing child mortality.
    Bustreo F; Okwo-Bele JM; Kamara L
    Arch Dis Child; 2015 Feb; 100 Suppl 1():S34-7. PubMed ID: 25613965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten years of the Global Alliance for Vaccines and Immunization: challenges and progress.
    Clemens J; Holmgren J; Kaufmann SH; Mantovani A
    Nat Immunol; 2010 Dec; 11(12):1069-72. PubMed ID: 21079627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The introduction of new vaccines into developing countries. IV: Global Access Strategies.
    Mahoney RT; Krattiger A; Clemens JD; Curtiss R
    Vaccine; 2007 May; 25(20):4003-11. PubMed ID: 17363119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines, inspiring innovation in health.
    Pagliusi S; Dennehy M; Kim H;
    Vaccine; 2018 Nov; 36(48):7430-7437. PubMed ID: 29789241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perceptions of the usefulness of external support to immunization coverage in Chad: an analysis of the GAVI-Alliance cash-based support.
    Ferrinho P; Dramé M; Tumusiime P
    Pan Afr Med J; 2013; 15():44. PubMed ID: 24106572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.